{"product_id":"survodutide-philippines","title":"Survodutide","description":"\u003ch2 data-section-id=\"cj80ku\" data-start=\"0\" data-end=\"19\" class=\"PDq2pG_selectionAnchorContainer\"\u003eSurvodutide 10mg\u003cspan aria-hidden=\"true\" class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003cp data-start=\"21\" data-end=\"536\"\u003eSurvodutide represents one of the most exciting developments in the next generation of metabolic peptides. Designed to build upon the success of earlier GLP-1 medications, Survodutide takes a different approach by combining \u003cstrong data-start=\"245\" data-end=\"274\"\u003eGLP-1 receptor activation\u003c\/strong\u003e with \u003cstrong data-start=\"280\" data-end=\"309\"\u003eglucagon receptor agonism\u003c\/strong\u003e, creating a dual mechanism that is intended to influence both appetite regulation and energy expenditure. This combination has made it one of the most closely watched investigational peptides currently in clinical development.\u003c\/p\u003e\n\u003cp data-start=\"538\" data-end=\"996\"\u003eWhile first-generation GLP-1 therapies demonstrated that targeting appetite could produce meaningful weight loss, Survodutide aims to go a step further. By activating both GLP-1 and glucagon receptors, it is designed not only to help reduce calorie intake but also to encourage the body to increase energy utilisation. This complementary mechanism has positioned Survodutide as one of the leading candidates among the newest generation of metabolic peptides.\u003c\/p\u003e\n\u003cp data-start=\"998\" data-end=\"1597\"\u003eClinical studies have generated considerable interest, with participants experiencing substantial reductions in body weight over the course of treatment. Survodutide has also attracted attention for its potential role in metabolic health beyond weight management, including encouraging findings in studies involving \u003cstrong data-start=\"1314\" data-end=\"1373\"\u003emetabolic dysfunction-associated steatohepatitis (MASH)\u003c\/strong\u003e, previously known as non-alcoholic steatohepatitis (NASH). These results have helped establish Survodutide as one of the most promising investigational peptides currently progressing through late-stage clinical development.\u003c\/p\u003e\n\u003cp data-start=\"1599\" data-end=\"1952\"\u003eBaseline Labs supplies \u003cstrong data-start=\"1622\" data-end=\"1642\"\u003eSurvodutide 10mg\u003c\/strong\u003e as a premium-quality lyophilised peptide in a sterile glass vial. Freeze-drying helps preserve peptide stability during storage and transport until reconstitution with bacteriostatic water. Every vial is professionally packaged and securely shipped with tracked nationwide delivery throughout the Philippines.\u003c\/p\u003e\n\u003cp data-start=\"1954\" data-end=\"2450\"\u003eWhether your interest lies in the latest advances in metabolic peptides or the next generation of GLP-based compounds, Survodutide has quickly become one of the most anticipated peptide developments because of its innovative dual-receptor mechanism and encouraging clinical progress. For more detailed information about Survodutide, including its mechanism of action, clinical development, product specifications, storage and reconstitution, continue to the \u003cstrong data-start=\"2412\" data-end=\"2435\"\u003eProduct Information\u003c\/strong\u003e section below.\u003c\/p\u003e","brand":"Baselinelabs.IS","offers":[{"title":"10mg","offer_id":49007489482907,"sku":"BL-SURVO-10","price":6500.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0773\/1675\/1515\/files\/Survodutide_10mg.png?v=1784256839","url":"https:\/\/www.baselinelabs.is\/products\/survodutide-philippines","provider":"Baselinelabs.is","version":"1.0","type":"link"}